Overview
Nick Onyemeke is a Hematologist Oncology specialist and a Hematologist in Ephrata, Pennsylvania. Dr. Onyemeke is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Onyemeke is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- INDEMNITY
- POS
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
460 N Reading Rd, Wellspan Medical Oncology, Ephrata, PA 17522
Temple Faculty Practice Plan Inc
Jessica Bauman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Bauman is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Polymorphous Low Grade Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma.
Irina Veytsman is a Hematologist Oncology specialist and a Hematologist in Harrisburg, Pennsylvania. Dr. Veytsman is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Childhood Iron Deficiency AnemiaDr. Onyemeke isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Advanced
- Acute Mountain SicknessDr. Onyemeke isAdvanced. Learn about Acute Mountain Sickness.
- AngiosarcomaDr. Onyemeke isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Onyemeke isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Onyemeke isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Onyemeke isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Inflammatory Breast CancerDr. Onyemeke isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Onyemeke isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Myeloblastic Leukemia with MaturationDr. Onyemeke isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Onyemeke isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Onyemeke isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Onyemeke isExperienced. Learn about Adult Immune Thrombocytopenia.
